The Wilms’ tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy

The Wilms tumor gene WT1 is a useful marker of clonal hematopoiesis and it has been shown to be a good marker of residual disease and it reflects the response to therapy. Although myelofibrosis is characterized by mutations of JAK2 and calreticulin (CALR), these mutations are not useful to monitor r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Gallo, Daniela, Nicoli, Paolo, Calabrese, Chiara, Gaidano, Valentina, Petiti, Jessica, Rosso, Valentina, Signorino, Elisabetta, Carturan, Sonia, Bot‐Sartor, Giada, Volpe, Gisella, Frassoni, Francesco, Saglio, Giuseppe, Cilloni, Daniela
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Commentary
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867666/
https://ncbi.nlm.nih.gov/pubmed/27167495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.735
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi